Up to 60% of patients with asthma or COPD use their inhaler incorrectly — and improper technique alone drives as much as 70% of the total healthcare cost of managing these conditions. Nothing in standard care actually measures how an inhaler is being used.
Figures are from the published sources named with each one. Each study describes its own patients and setting. Results from a published study do not predict results for patients in these programs, and Synchronize Health makes no claim that its results will match those published.
Synchronize Health's RPM/CCM platform closes that gap with the CapMedic MDI device, which tracks the specifics that matter — date and time of use, shake duration, inhaler orientation, and inhalation technique — the same details that determine whether medication reaches the lungs or gets deposited on the tongue and the roof of the mouth.
The device doubles as a spirometer, giving physicians objective lung-function data to track disease progression and adjust treatment. The chronic care team turns adherence data into personalized feedback and targeted education — not generic reminders — while missed doses and declining adherence are surfaced to the care team for timely outreach.
Patients get specific, correctable feedback. Physicians get the data to know whether it's a disease problem or a technique problem — before it becomes an ED visit.
The device measures what standard care never has, so a technique problem gets corrected as a technique problem — not discovered as an exacerbation.